MedPath

Management of Cervical Intraepithelial Neoplasia Grade 2

Phase 4
Completed
Conditions
Cervical Intraepithelial Neoplasia
Registration Number
NCT00733109
Lead Sponsor
Universidade Cidade de Sao Paulo
Brief Summary

The aim of this study was to compare two management options for CIN 2. This randomized clinical trial performed between 2003 and 2006. A series of 90 Brazilian women diagnosed as CIN2 were randomized into two groups: 1) 45 whose lesion was excised and,2) 45 women subjected to follow-up at 3-month intervals for 12 months.

Detailed Description

Pap smear and colposcopy were performed at every follow-up visit and all lesions were completely visible at colposcopy.

The researchers purpose was to make some comments about the over treatment and the misclassification of CIN 2.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
90
Inclusion Criteria
  • Histological CIN2 diagnosis
Exclusion Criteria
  • Previous CIN treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
43 women in the follow-up group, 44.1% experienced spontaneous regression, 20.9% had partial regression, 23.2% progressed to CIN3, and 11.6% showed persistence. 44 women whose lesion was excised, the regression rate was 90.9%12 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Leonor Mendes de Barros Maternity Hospital

🇧🇷

São Paulo, Brazil

Leonor Mendes de Barros Maternity Hospital
🇧🇷São Paulo, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.